Cargando…
The lived experience of a novel disruptive therapy in a group of men and boys with haemophilia A with inhibitors: Emi & Me
BACKGROUND: People with haemophilia A and inhibitors (PwHi) suffer more orthopaedic complications, bleeding and pain than those without inhibitors. The advent of emicizumab as a prophylactic treatment has led to a reduction in bleed frequency and a significant improvement in overall quality of life....
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849246/ https://www.ncbi.nlm.nih.gov/pubmed/34878209 http://dx.doi.org/10.1111/hex.13404 |